Nucleoside and Nucleotide Reverse Transcriptase Inhibitors

All categories
DBCAT002376Therapeutic categoryJ05AF

A DrugBank category of 13 drugs. 12 of them are approved.

ATC classification
Also known as
Antiviral nucleoside and nucleotide reverse transcriptase inhibitors
Drugs

What you can answer from here — as of May 26, 2021

13DrugsEach linked to its full drug card
Listed above
13Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,407Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
4Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Nucleoside and Nucleotide Reverse Transcriptase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In